Skip to main content
ENERGENESIS logo

ENERGENESIS — Investor Relations & Filings

Ticker · 6657 ISIN · TW0006657000 TW Professional, scientific and technical activities
Open in API
Filings indexed 35 across all filing types
Latest filing 2026-04-10 Proxy Solicitation & In…
Country TW Taiwan
Listing TW 6657

About ENERGENESIS

http://www.energenesis-biomedical.com

Energenesis Biomedical Co., Ltd. specializes in the research and development of innovative pharmaceuticals through its proprietary ENERGI drug development platform. The company focuses on the activation of AMP-activated protein kinase (AMPK), a critical enzyme for cellular energy regulation, to develop therapeutic solutions for various diseases. Its core pipeline centers on small molecule purine compounds designed to modulate cellular energy metabolism. Operating with an intellectual property-driven strategy, the company manages the development cycle from early-stage drug discovery through clinical trial validation. Energenesis Biomedical aims to increase the value of its proprietary technologies for strategic out-licensing and collaboration with global pharmaceutical partners. In addition to drug development, the company offers specialized testing and analysis services and distributes research reagents.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議召開115年股東常會相關事宜-新增議案
Proxy Solicitation & Information Statement Classification · 82% confidence The document is a company disclosure announcing the board’s resolution to convene the annual shareholders’ meeting, including meeting date, venue, agenda items to report, approve, and discuss. It is not the full annual report (10-K), not an earnings release, nor a dividend notice. It also does not describe a change in board members (MANG) or legal proceedings. Instead, it provides the agenda and materials to be voted on at the meeting, matching the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-10 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 90% confidence The document is a detailed tabular disclosure of shareholdings and monthly changes for company insiders (directors, chairman, vice chairman, general manager, and department heads) including their personal, spousal, and trust holdings. This aligns with insider transaction/shareholding reports required for directors and executives rather than a financial report or announcement. Therefore, it should be classified under Director’s Dealing (DIRS).
2026-04-07 Chinese
115年03月董事會成員及持股
Director's Dealing Classification · 94% confidence The document is a Taiwanese “內部人持股異動事後申報表” showing shareholdings and pledged shares of company directors, supervisors, and senior management. It lists personal insider holdings (original and current), pledge details, and related parties’ holdings – a classic insider dealing disclosure. Therefore, it fits the “Director's Dealing” category.
2026-04-07 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 85% confidence The document is a brief statutory disclosure from a Taiwanese listed company (‘華安’) on the Public Information Observatory about its fund lending and endorsement/guarantee balances (all zeros). It is not an annual or interim report, earnings release, management discussion, or any specific financing or M&A announcement. This is a routine regulatory filing required by the exchange. Therefore it falls under the generic Regulatory Filings category (RNS).
2026-04-07 Chinese
115年3月營業收入
Regulatory Filings Classification · 85% confidence The document is a monthly operating revenue summary from the Taiwan MOPS public information platform, including actual net revenue figures, comparisons and explanations. It is not a full interim or annual report, earnings release, dividend notice, or other specific category. The company is directly disclosing regulatory‐mandated monthly revenue data. There is no dedicated category for monthly revenue disclosures in the taxonomy, so the correct classification is the fallback “Regulatory Filings” (RNS).
2026-04-07 Chinese

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.